Surgery & Treatments
NEWPORT BEACH, CA: NEWPORT BEACH, CA -- (Marketwire) -- 11/05/12 -- is now enrolling patients with Keratoconus in its Collagen Cross Linking Clinical Trial. This is a physician-sponsored clinical trial; for Collagen C ...
LAWRENCEVILLE, NJ: LAWRENCEVILLE, NJ -- (Marketwire) -- 11/02/12 -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that it would hold a conference call to discuss third ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 11/01/12 -- In the news release "Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results," issued earlier today by Onyx Pharmaceuticals ...
SOUTH SAN FRANCISCO, CA: Kyprolis Net Sales of $18.6 Million in Launch Quarter; Stivarga Launch Underway in U.S. ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/29/12 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it has rescheduled its third quarter 2012 financial report and conference call du ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 10/29/12 -- NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, feature ...
SUNRISE, FL: SUNRISE, FL -- (Marketwire) -- 10/29/12 -- Bioheart, Inc. (OTCQB: BHRT) has announced that it will initiate its ANGEL trial in Mexico at the Hospital Angeles with the Regenerative Medicine Institute ...
BEVERLY, MA: Elsevier Business Intelligence Reports Cellceutix "Developing a Still-Secret Prodrug For Psoriasis" and a "Heralded Cancer Candidate" ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 10/26/12 -- NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today a ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 10/24/12 -- NuVasive, Inc. (NASDAQ: NUVA)NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and proc ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 10/18/12 -- TNI BioTech, Inc. (PINKSHEETS: TNIB) and Hubei Qianjiang Pharmaceutical Co., Ltd., a leading Chinese pharmaceutical company, today announced an agreement t ...
SUNRISE, FL: SUNRISE, FL -- (Marketwire) -- 10/17/12 -- Bioheart, Inc. (OTCQB: BHRT) today announced that they have agreed to extend the license agreement with Airspeed for four separate Bioheart patents. The pat ...
SCOTTSDALE, AZ: SCOTTSDALE, AZ -- (Marketwire) -- 10/16/12 -- MediaTechnics Corporation (PINKSHEETS: MEDT) is pleased to announce that it executed an agreement to purchase MedLaw Capital LLC. of Fountain Hills, Ariz ...
SAN DIEGO, CA: Dr. Parikh Has Been Bestowed This Honor Three Years in a Row ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 10/15/12 -- Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that the company completed enrollment in the FOCUS trial, an international Phase 3 cli ...
LONDON and TURKU, FINLAND: LONDON and TURKU, FINLAND -- (Marketwire) -- 10/15/12 -- Ark Therapeutics has been selected to manufacture and supply Lymfactin™ to Laurantis Pharma under a conditional agreement announced today by ...
NEW YORK, NY and POTOMAC MD: NEW YORK, NY and POTOMAC MD -- (Marketwire) -- 10/11/12 -- TNI BioTech, Inc. (PINKSHEETS: TNIB), a public company operating in the biotech sector, announced today the signing of an agreement with Pha ...
SUNRISE, FL: SUNRISE, FL -- (Marketwire) -- 10/11/12 -- Bioheart, Inc. (OTCQB: BHRT) presented at the 2012 annual AABB (formerly the American Association of Blood Banks) conference in Boston, MA. Bioheart's ...
SARATOGA, CA: Reimbursement Allows Florida Medicare Beneficiaries Access to New Treatment Option for End-Stage Age-Related Macular Degeneration (AMD) ...
MANHATTAN, NY: MANHATTAN, NY -- (Marketwire) -- 10/08/12 -- With plastic surgery growing in popularity, knowing how to properly address a recent surgery or interact with someone who has "gone under the knife&q ...
